U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
| Name | Elizabeth K. Rucki |
|---|---|
| Address | GlaxoSmithKline 410 Blackwell Street Legal Brand Protection Durham,NC 27701 |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Sep-14-2021 | NEW APPLICATION ENTERED | NWAPI | |
| Oct-19-2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Jun-14-2022 | ASSIGNED TO EXAMINER | DOCKD | |
| Jun-14-2022 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
| Jun-17-2022 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | ERRRO | |
| Jun-23-2022 | ELECTRONIC RECORD REVIEW COMPLETE | FIXDO | |
| Jul-06-2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
| Jul-26-2022 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Jul-26-2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
| Aug-25-2022 | EXTENSION OF TIME TO OPPOSE RECEIVED | ETOFT | |
| Aug-25-2022 | TEAS POST PUBLICATION AMENDMENT RECEIVED | EPPAI | |
| Sep-13-2022 | ASSIGNED TO PETITION STAFF | APETA | |
| Sep-19-2022 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | CHPBI | |
| Oct-04-2022 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | ETOPT | |
| Nov-08-2022 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
| Nov-08-2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED | NRCCE | |
| Nov-08-2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED | COARI | |
| Nov-08-2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | REAPI | |
| Nov-08-2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | ARAAI | |
| Nov-08-2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | TCCAI | |
| Nov-08-2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | CHANI | |
| Aug-11-2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED | COARI | |
| Aug-11-2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | CHANI | |
| Aug-11-2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | REAPI | |
| Aug-11-2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | ARAAI | |
| Aug-11-2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | TCCAI |